Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from MedAdvisor Limited ( (AU:MDR) ) is now available.
MedAdvisor Limited has announced an extension to its Share Purchase Plan (SPP) deadline, moving it from April 30, 2025, to May 9, 2025. This extension aims to provide eligible shareholders additional time to participate and complete their applications, potentially impacting shareholder engagement and investment levels.
More about MedAdvisor Limited
MedAdvisor Solutions (ASX: MDR) is a global leader in pharmacy-driven patient engagement solutions, offering personalized patient experiences to simplify the medication journey. Utilizing THRiV, a cloud-based, AI-enabled platform, the company enhances pharmacy workflow and patient engagement. MedAdvisor collaborates with over 34,000 pharmacies in the US, reaching more than two-thirds of the population, and is used by over 95% of Australian pharmacies, connecting with over 3.7 million patients.
YTD Price Performance: -57.33%
Average Trading Volume: 625,297
Technical Sentiment Signal: Buy
Current Market Cap: A$57.38M
Find detailed analytics on MDR stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue